<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03619499</url>
  </required_header>
  <id_info>
    <org_study_id>NIVVIVIMOB</org_study_id>
    <nct_id>NCT03619499</nct_id>
  </id_info>
  <brief_title>Non Invasive Ventilation in Bronchiolitis</brief_title>
  <official_title>Non Invasive Ventilation Versus Invasive Ventilation in Management of Bronchiolitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is decided to perform a prospective study in a non-selected population of infants with
      bronchiolitis during one year ( October.2018 to October.2019) to study the characteristics,
      clinical course and outcome of the use of Non invasive ventilation in the management and
      compare the results with those treated with invasive ventilation to assess safety and
      efficacy and inform guideline construction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute viral bronchiolitis is one of the most common respiratory diseases in early childhood
      and is a major health problem worldwide. The seasonal burden of the disease, the number of
      hospitalizations each year and the risk of subsequent asthma bring about substantial costs in
      developed countries. Respiratory syncytial virus and Human Rhinovirus seem to be the most
      frequent etiologic agents, but other viruses such as human Metapneumovirus, Influenza virus,
      and Parainfluenza virus can also be involved. The spectrum of clinical outcomes is wide, but
      bronchiolitis is more severe when caused by Respiratory syncytial virus. In contrast, while
      Human Rhinovirus is involved in milder forms, it is more likely to be associated with
      recurrent wheezing in infancy. Acute respiratory failure from pneumonia, influenza, and
      respiratory syncytial virus is responsible for 4.25 million deaths world-wide and the leading
      cause of mortality in low and middle-income countries. In the United Kingdom up to 7% of
      bronchiolitis admissions require intensive care for ventilatory support. One third of
      unplanned infant admissions to pediatric intensive care units have respiratory failure, the
      majority due to bronchiolitis, require invasive mechanical ventilation for 4-7 days and a
      prolonged hospital stay. In countries where there is no retrieval infrastructure, the need to
      develop safe and effective alternatives to invasive ventilation and pediatric intensive care
      unit admission is acute. However, none of the interventions commonly used for infants
      admitted with bronchiolitis is backed by robust evidence of benefit for clinically
      significant outcomes, making this a pressing subject for further study. Typically, intensive
      respiratory support for bronchiolitis is via invasive mechanical ventilation through an
      artificial airway, an intervention with recognized complications in infants. There is
      evidence to support the use of non-invasive ventilation in pediatric acute respiratory
      failure of variable causes.Although evidence for use in bronchiolitis is increasing,clinical
      acceptance is not universal and published best practice guidelines are not easily available.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>decrease risk of respiratory failure</measure>
    <time_frame>2 days</time_frame>
    <description>in the form of ( pulse oximetry less than 94‚Åí, pao2 less than 60mmHg, paco2 more than 84mmHg ) while on NIV that lead to connection to invasive mechanical ventilation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>decrease length of hospital stay</measure>
    <time_frame>7 days</time_frame>
    <description>by prevention of ventilation acquired pneumonia and barotrauma that occur from use of invasive ventilation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Non Invasive Ventilation</condition>
  <arm_group>
    <arm_group_label>non invasive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infants who fulfill criteria of severe bronchiolitis will be connected to non invasive ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>invasive</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>infants who were connected to invasive mechanical ventilation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>non invasive ventilation</intervention_name>
    <description>patients who will fulfill the criteria of severe bronchiolitis will be connected to non invasive ventilation including continuous positive airway pressure via nasal prongs or nasal mask. Mode of ventilation, inspired oxygen levels, oxygen saturation, respiratory rate, and blood gas values from arterial samples prior to and after 2 and 4 hrs of ventilation or nearest time, will be documented.</description>
    <arm_group_label>non invasive</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all infants with acute severe bronchiolitis,

          -  infants aged below 1 year.

        Exclusion Criteria:

          -  patients who have contraindications for NIV (patients with maxillofacial trauma,
             gastrointestinal obstruction and severe secretion),

          -  Children who had suspected or confirmed underlying chronic diseases (i.e., cystic
             fibrosis, chronic pulmonary disease, congenital heart disease, bronchopulmonary
             disease, prematurity,

          -  Children who had already more than one wheezing episode.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>azza el tayeb</last_name>
    <phone>01006863277</phone>
    <email>azeltayeb@aun.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ismail Lotfy</last_name>
    <phone>01063398967</phone>
    <email>Ismail231@aun.edu.eg</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Andreola B, Bressan S, Callegaro S, Liverani A, Plebani M, Da Dalt L. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J. 2007 Aug;26(8):672-7.</citation>
    <PMID>17848876</PMID>
  </results_reference>
  <results_reference>
    <citation>Feuillet F, Lina B, Rosa-Calatrava M, Boivin G. Ten years of human metapneumovirus research. J Clin Virol. 2012 Feb;53(2):97-105. doi: 10.1016/j.jcv.2011.10.002. Epub 2011 Nov 9. Review.</citation>
    <PMID>22074934</PMID>
  </results_reference>
  <results_reference>
    <citation>Gern JE. The ABCs of rhinoviruses, wheezing, and asthma. J Virol. 2010 Aug;84(15):7418-26. doi: 10.1128/JVI.02290-09. Epub 2010 Apr 7. Review.</citation>
    <PMID>20375160</PMID>
  </results_reference>
  <results_reference>
    <citation>Koponen P, Helminen M, Paassilta M, Luukkaala T, Korppi M. Preschool asthma after bronchiolitis in infancy. Eur Respir J. 2012 Jan;39(1):76-80. doi: 10.1183/09031936.00040211. Epub 2011 Jun 23.</citation>
    <PMID>21700604</PMID>
  </results_reference>
  <results_reference>
    <citation>Mathew JL. What works in bronchiolitis? Indian Pediatr. 2009 Feb;46(2):154-8.</citation>
    <PMID>19242034</PMID>
  </results_reference>
  <results_reference>
    <citation>Marguet C, Lubrano M, Gueudin M, Le Roux P, Deschildre A, Forget C, Couderc L, Siret D, Donnou MD, Bubenheim M, Vabret A, Freymuth F. In very young infants severity of acute bronchiolitis depends on carried viruses. PLoS One. 2009;4(2):e4596. doi: 10.1371/journal.pone.0004596. Epub 2009 Feb 25.</citation>
    <PMID>19240806</PMID>
  </results_reference>
  <results_reference>
    <citation>Midulla F, Pierangeli A, Cangiano G, Bonci E, Salvadei S, Scagnolari C, Moretti C, Antonelli G, Ferro V, Papoff P. Rhinovirus bronchiolitis and recurrent wheezing: 1-year follow-up. Eur Respir J. 2012 Feb;39(2):396-402. doi: 10.1183/09031936.00188210. Epub 2011 Aug 18.</citation>
    <PMID>21852336</PMID>
  </results_reference>
  <results_reference>
    <citation>Khilnani P, Singhi S, Lodha R, Santhanam I, Sachdev A, Chugh K, Jaishree M, Ranjit S, Ramachandran B, Ali U, Udani S, Uttam R, Deopujari S. Pediatric Sepsis Guidelines: Summary for resource-limited countries. Indian J Crit Care Med. 2010 Jan;14(1):41-52. doi: 10.4103/0972-5229.63029.</citation>
    <PMID>20606908</PMID>
  </results_reference>
  <results_reference>
    <citation>American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006 Oct;118(4):1774-93.</citation>
    <PMID>17015575</PMID>
  </results_reference>
  <results_reference>
    <citation>Valkonen H, Waris M, Ruohola A, Ruuskanen O, Heikkinen T. Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: a 3-year follow-up. Allergy. 2009 Sep;64(9):1359-65. doi: 10.1111/j.1398-9995.2009.02022.x. Epub 2009 Mar 23.</citation>
    <PMID>19416146</PMID>
  </results_reference>
  <results_reference>
    <citation>Wainwright C, Altamirano L, Cheney M, Cheney J, Barber S, Price D, Moloney S, Kimberley A, Woolfield N, Cadzow S, Fiumara F, Wilson P, Mego S, VandeVelde D, Sanders S, O'Rourke P, Francis P. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med. 2003 Jul 3;349(1):27-35.</citation>
    <PMID>12840089</PMID>
  </results_reference>
  <results_reference>
    <citation>Ya√±ez LJ, Yunge M, Emilfork M, Lapadula M, Alc√°ntara A, Fern√°ndez C, Lozano J, Contreras M, Conto L, Arevalo C, Gayan A, Hern√°ndez F, Pedraza M, Feddersen M, Bejares M, Morales M, Mallea F, Glasinovic M, Cavada G. A prospective, randomized, controlled trial of noninvasive ventilation in pediatric acute respiratory failure. Pediatr Crit Care Med. 2008 Sep;9(5):484-9. doi: 10.1097/PCC.0b013e318184989f. Erratum in: Pediatr Crit Care Med. 2008 Nov;9(6):672.</citation>
    <PMID>18679148</PMID>
  </results_reference>
  <results_reference>
    <citation>Zorc JJ, Hall CB. Bronchiolitis: recent evidence on diagnosis and management. Pediatrics. 2010 Feb;125(2):342-9. doi: 10.1542/peds.2009-2092. Epub 2010 Jan 25. Review.</citation>
    <PMID>20100768</PMID>
  </results_reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>July 24, 2018</study_first_submitted>
  <study_first_submitted_qc>August 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2018</study_first_posted>
  <last_update_submitted>January 8, 2019</last_update_submitted>
  <last_update_submitted_qc>January 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohammed Omran</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

